Skip to main content
SpringerLink
Log in

Prostatakarzinom

  • Conference paper
Prostatakarzinom Malignes Melanom Bildgebende Verfahren in der Onkologie

Part of the book series: Angewandte Onkologie ((AONKOLOGIE))

  • 25 Accesses

Zusammenfassung

Die Inzidenz des Prostatakarzinoms, d. h. jene Anzahl neuer Erkrankungen an Prostatakarzinom pro 100.000 Einwohner pro Jahr, liegt in den Vereinigten Staaten bei etwa 69 [1].Verbesserte Diagnostik und gesetzlich verankerte Krebsregister scheinen zur Zunahme der Prostatakarzinominzidenz beizutragen (Abb.1). In Österreich ist das Prostatakarzinom der zweithäufigste maligne Tumor bei Männern; bei über 65jährigen der häufigste (Abb. 2). Das Prostatakarzinom ist somit ein Malignom des älteren Mannes mit einem Gipfel im 7. und 8. Lebensjahrzehnt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Young JL Jr, Perey CL, Asire AJ, et al (1981) Cancer incidence and mortality in the United States, 1973–1977. Natl Cancer Inst Monogr 57: 1

    PubMed  Google Scholar 

  2. Silverberg E, Lubera JA (1983) A review of American Cancer Society estimates of cancer cases and deaths. CA 33: 2

    PubMed  CAS  Google Scholar 

  3. Baba S, Jacobi GH (1980) Epidemiologie des Prostatakarzinoms. Akt Urol 11: 277

    Article  Google Scholar 

  4. Woolf CM (1960) An investigation of the familial aspects of carcinoma of the prostate. Cancer 13: 739

    Article  PubMed  CAS  Google Scholar 

  5. Schuman LM, Mandel J, Blackard C, et al (1977) Epidemiologic study of prostatic cancer: preliminary report. Cancer Treat Rep 61: 181

    PubMed  CAS  Google Scholar 

  6. Barry JM, Goldstein A, Hubbard M (1980) Human leukocyte A and B antigens in patients with prostatic adenocarcinoma. J Urol 124: 847

    PubMed  CAS  Google Scholar 

  7. Hutchison GB (1981) Incidence and etiology of prostate cancer. Urology 17 [Suppl]: 4

    PubMed  CAS  Google Scholar 

  8. Wynder EL, Mabuchi K, Whitmore WF Jr (1971) Epidemiology of cancer of the prostate. Cancer 28: 344

    Article  PubMed  CAS  Google Scholar 

  9. Blair A, Fraumeni JF Jr (1978) Geographic patterns of prostate cancer in the United States. J Natl Cancer Inst 61: 1379

    PubMed  CAS  Google Scholar 

  10. Yatani R, Chigusa I, Akazaki K, et al (1982) Geographic pathology of latent prostatic carcinoma. Int J Cancer 29: 611

    Article  PubMed  CAS  Google Scholar 

  11. Winkelstein Wit., Ernster VL (1979) Epidemiology and etiology. In: Murphy GP (ed) Prostatic cancer. P.S.G. Publishing Company, Littleton, p1

    Google Scholar 

  12. Noble RL (1977)The development of prostatic adenocarcinoma in Nb rats following prolonged sex hormone administration. Cancer Res 37:1929

    PubMed  CAS  Google Scholar 

  13. Moore RA (1936) The evolution and involution of the prostate gland. Am J Pathol 12: 599

    PubMed  CAS  Google Scholar 

  14. Zumoff B, Levin J, Strain GW, et al (1982)Abnormal levels of plasma hormones in men with prostate cancer: evidence towards a „two-disease“ theory. Prostate 3: 579

    Article  PubMed  CAS  Google Scholar 

  15. Armenian HK, Lilienfeld AM, Diamond EL, et al (1975) Epidemiologic characteristics of patients with prostatic neoplasms. Am J Epidemiol 102: 47

    PubMed  CAS  Google Scholar 

  16. Armenian HK, Lilienfeld AM, Diamond EL, et al (1974) Relation between benign prostatic hyperplasia and cancer of the prostate: a prospective and retrospective study. Lancet ii: 115

    Google Scholar 

  17. Greenwald P, Kirms V, Polan AK, et al (1974) Cancer of the prostate among men with benign prostatic hyperplasia. J Natl Cancer Inst 53: 335

    PubMed  CAS  Google Scholar 

  18. Winkelstein W Jr, Sacks ST, Ernster VL, et al (1977) Correlations of incidence rates for selected cancers in the nine areas of the Third National Cancer Survey. Am J Epidemiol 105: 407

    PubMed  Google Scholar 

  19. Catalona WJ, Scott WW (1986) Carcinoma of the prostate. In: Walsh PC, Gittes RF, Perlmutter AD, et al (eds) Campbell’s urology, vol 2. Saunders, Philadelphia, p 1463

    Google Scholar 

  20. Dunn JE (1975) Cancer epidemiology in populations of the United States — with emphasis on Hawaii and California and Japan. Cancer Res 35: 3240

    PubMed  CAS  Google Scholar 

  21. Ross RK, Deapen DM, Casagrande JT, et al (1981) A cohort study of mortality from cancer of the prostate in Catholic priests. Br J Cancer 43: 233

    Article  PubMed  CAS  Google Scholar 

  22. Paulson DE, Rabson AS, Fraley EE (1968) Viral neoplastic transformation of hamster prostate tissue in vitro. Science 159: 200

    Article  PubMed  CAS  Google Scholar 

  23. Centifano YM, Kauffman HE, Zam ZS, et al (1973) Herpes virus particles in prostatic carcinoma cells. J Virol 12: 1608

    Google Scholar 

  24. Herbert JT, Birkhoff JD, Feorino PM, et al (1976) Herpes simplex virus type 2 and cancer of the prostate. J Urol 116: 611

    PubMed  CAS  Google Scholar 

  25. Rodin AE, Larson DL, Roberts DK (1967) Nature of the perineural space invaded by prostatic carcinoma. Cancer 20: 1772

    Article  PubMed  CAS  Google Scholar 

  26. Mostofi FK, Price EB (1973) Tumors of the male genital system. In: Atlas on tumor pathology, series 2, fast 8. Armed Forces Institute of Pathology, Washington, p 196

    Google Scholar 

  27. Utz DC, Farrow GM (1969) Pathologic differentiation and prognosis of prostatic carcinoma. JAMA 209: 1701

    Article  PubMed  CAS  Google Scholar 

  28. Mostofi FK (1976) Problems of grading in carcinoma of prostate. Semin Oncol 3: 161

    PubMed  CAS  Google Scholar 

  29. Epstein NA, Fatti LP (1976) Prostatic carcinoma: some morphological features affecting prognosis. Cancer 37: 2455

    Article  PubMed  CAS  Google Scholar 

  30. Gleason DF (Veterans Administration Cooperative Urological Research Group) (1977) Histologic grading and clinical staging of prostatic carcinoma. In:Tannenbaum M (ed) Urologic pathology: the prostate. Lea & Febiger, Philadelphia, p 171

    Google Scholar 

  31. Harada M, Mostofi FK, Corle DK, et al (1977) Preliminary studies of histologic prognosis in cancer of the prostate. Cancer Treat Rep 61: 223

    PubMed  CAS  Google Scholar 

  32. Esposti PL (1971) Cytologic malignancy grading of prostatic carcinoma by tansrectal aspiration biopsy. Scand J Urol Nephrol 5: 199

    Article  PubMed  CAS  Google Scholar 

  33. Chodak GW, Bibbo M, Straus FH, et al (1986) Transrectal aspiration biopsy versus transperineal core biopsy for the diagnosis of carcinoma of the prostate. J Urol 132: 480

    Google Scholar 

  34. Kofler K, Schmidbauer C (1977) Zur Frage des sogenannten Ubergangszellkarzinoms der Prostata and seiner Onkogenese. Z Urol 70: 569

    CAS  Google Scholar 

  35. Dhom G (1981) Pathologie des Prostatakarzinoms. In: Verhandlungsberichte der Deutschen Gesellschaft für Urologie. Springer, Berlin Heidelberg New York, S 9

    Google Scholar 

  36. Kihl B, Bratt CG (1981) Reimplantation of the ureter in prostatic carcinoma associated with bilateral ureteric obstruction. Br) Urol 53: 349

    Article  CAS  Google Scholar 

  37. Byar DP, Mostofi FK (Veterans Administration Cooperative Urological Research Group) (1972) Carcinoma of the prostate: prognostic evaluation of certain pathologic features in 208 radical prostatectomies. Examined by the step-section technique. Cancer 30: 5

    Google Scholar 

  38. Winter CC (1957)The problem of rectal involvement by prostatic cancer. Surg Gynecol Obstet 105:136

    PubMed  CAS  Google Scholar 

  39. McLaughlin AP, Saltzstein SL, McCullogh DL, et al (1976) Prostatic carcinoma: incidence and location of unsuspected lymphatic metastases.) Urol 115: 89

    CAS  Google Scholar 

  40. Willis RA(1973) Secondarytumours of bones. In:The spread of tumours in the human body, 3rd edn. Butterworths, London, p 229

    Google Scholar 

  41. Jacobs SC (1983) Spread of prostatic cancer to bone. Urology 21: 337

    Article  PubMed  CAS  Google Scholar 

  42. Whitmore WF Jr (1973) The natural history of prostatic cancer. Cancer 32: 1104

    Article  PubMed  Google Scholar 

  43. Murphy GP, Natarajan N, Pontes) E, et al (1982)The national survey of prostate cancer in the United States by the American College of Surgeons.) Urol 127: 928

    CAS  Google Scholar 

  44. Levine RL,Wilchinsky M(1979)Adenocarcinoma of the prostate:a comparison of the disease in blacks versus whites. J Urol 121:761

    PubMed  CAS  Google Scholar 

  45. Catalona WJ, Smolev J K, Harty)] (1975) Prognostic value of host immunocompetence in urologic cancer patients. J Urol 114: 922

    CAS  Google Scholar 

  46. Smith JAJr, Middleton RG (1982) Pelvic lymph node metastasis from prostatic cancer: influence of tumor grade and stage. Proc Meeting American Urological Association (abstract # 238)

    Google Scholar 

  47. Diamond DA, Berry SI, Jewett HJ, et al (1982) A new method to assess metastatic potential of human prostate cancer: relative nuclear roundness.) Urol 128:729

    CAS  Google Scholar 

  48. Trachtenberg J, Walsh PC (1982) Correlation of prostatic nuclear androgen receptor content with duration of response and survival following hormonal therapy in advanced prostatic cancer. J Urol 127: 466

    PubMed  CAS  Google Scholar 

  49. Cantrell BB, DeKlerk DP, Eggleston JC, et al (1981) Pathologic factors that influenceprognosis in stage A prostatic cancer: the influence of extent versus grade. J Urol 125:516

    PubMed  CAS  Google Scholar 

  50. Blackard CE, Byar DP, Jordan WP Jr (Veterans Administration Cooperative Urological Research Group) (1973) Orchiectomyforadvanced prostatic carcinoma: a reevaluation. Urology 1: 553

    Article  PubMed  CAS  Google Scholar 

  51. Slack NH, Mittelman A, Brady MF, et al (Investigators in the National Prostatic Cancer Project) (1980) The importance of the stable category for chemotherapy treatment patients with advanced and relapsing prostate cancer. Cancer 46: 2393

    Google Scholar 

  52. Emmett JL, Barber KW Jr, Jackmann RJ (1961) Transrectal biopsy to detect prostatic carcinoma: a review and report of 203 cases.Trans Am Assoc Genitourin Surg 53: 460

    Google Scholar 

  53. Packer MG, Russo P, FairWR (1984) Prophylactic antibiotics and Foley catheter usage in transperineal needle biopsy of the prostate. J Urol 131: 687

    PubMed  CAS  Google Scholar 

  54. Sharifi R, Shaw M, Ray V, et al (1983) Evaluation of cytologic techniques for diagnosis of prostate cancer. Urology 21: 417

    Article  PubMed  CAS  Google Scholar 

  55. Bauer HW(1986)Was leistet die immunchemische PAP-Bestimmung beim Prostatakarzinom. In: BauerHW, Fröschle MC (Hrsg) Neue Erkenntnisse zur klinischen Wertigkeit und Methodik der sauren Prostataphosphatase. Gil Verlag, Darmstadt, S 29

    Google Scholar 

  56. Myrtle JF, Klimley PG, Ivor LP, et al (1986) Clinical utility of prostate specific antigen (PSA) in the management of prostate cancer. In: Advances of cancer diagnostics. Hybritech Inc, San Diego, p 1

    Google Scholar 

  57. Lachman E (1955) Osteoporosis —the potentialities and limitations of its roentgenologic diagnosis. Am J Roentgenol Radium Ther Nucl Med 74: 712

    Google Scholar 

  58. Donohue RE, Mani JH, Whitesel JA, et al (1982) Pelvic lymph node dissection: guide to patient management in clinically locally confined adenocarcinoma of prostate. Urology 20: 559

    Article  PubMed  CAS  Google Scholar 

  59. Bouffioux C (1979) Le cancer de la prostate. Acta Urol Belg 47: 201

    Google Scholar 

  60. Hoekstra WJ, Schroeder FH (1981) The role of lymphangiography in the staging of prostatic cancer. Prostate 2: 433

    Article  PubMed  CAS  Google Scholar 

  61. Benson KH, Watson RA, Spring DB, et al (1981) The value of computerized tomography in evaluation of pelvic lymph nodes.) Urol 126: 63

    CAS  Google Scholar 

  62. Weinerman PM, Arger PH, Coleman BG, et al (1983) Pelvic and bladder adenopathy from bladder and prostate carcinoma: detection by rapid sequence computed tomography. Am J Radiol 140: 95

    CAS  Google Scholar 

  63. Paulson DF (1980) The prognostic role of lymphadenectomy in adenocarcinoma of the prostate. Urol Clin North Am 7: 615

    PubMed  CAS  Google Scholar 

  64. Jacobi GH (1982) Tumore der Prostata und Samenblase. In: Hohenfellner R (Hrsg) Urologie in Klinik und Praxis, Bd 1.Thieme, Stuttgart New York, S 566

    Google Scholar 

  65. Bridges CH, Belville WD, Insalaco Si, et al (1983) Stage A prostatic carcinoma and repeat transurethral resection: a reappraisal 5 years later. J Urol 129: 307

    PubMed  CAS  Google Scholar 

  66. Denton SE, Choy SH, Valk WL (1965) Occult prostatic carcinoma diagnosed by the step section technique of the surgical specimen. J Urol 93: 296

    PubMed  CAS  Google Scholar 

  67. Kastendieck H, Bressel M (1980)Vergleichende Analyse der klinischen und morphologischen Klassifikation (Staging) von 165 Prostatakarzinomen nach radikaler Prostatektomie. Urologe [A] 19: 331

    CAS  Google Scholar 

  68. Young HH (1905) The early diagnosis and radical cure of carcinoma of the prostate. Being a study of 40 cases and presentation of a radical operation which was carried out in 4 cases. Bull Johns Hopkins Hosp 16: 315

    Google Scholar 

  69. Benson RC Jr, Tomera KM, Zincke H, et al (1984) Bilateral pelvic lymphadenectomy and radical retropubic prostatectomy for adenocarcinoma confined to the prostate. J Urol 131: 1103

    PubMed  Google Scholar 

  70. Walsh PC, Jewett HJ (1980) Radical surgery for prostatic cancer. Cancer 45: 1906

    PubMed  CAS  Google Scholar 

  71. Elder JS, Jewett HJ, Walsh PC (1982) Radical perinea) prostatectomy for clinical stage B2 carcinoma of the prostate. J Urol 127: 704

    PubMed  CAS  Google Scholar 

  72. Paulson DF, Lin GH, Hinshaw W, et al (Uro-Oncology Research Group) (1982) Radical surgery versus radiotherapy for adenocarcinoma of the prostate. J Urol 128: 502

    PubMed  CAS  Google Scholar 

  73. Byar DP, Corle DK(Veterans Administration Cooperative Urological Research Group) (1981)VACURG randomized trial of radical prostatectomy for stages I and II prostate cancer. Urology 17 [Suppl:7

    Google Scholar 

  74. Schroeder FH, Belt E (1975) Carcinoma of the prostate: a study of 213 patients with stage C tumors treated by total perineal prostatectomy. J Urol 114: 257

    PubMed  CAS  Google Scholar 

  75. De Vere White R, Paulson DE, Glenn JF (1977)The clinical spectrum of prostate cancer. J Urol 117: 323

    Google Scholar 

  76. Scott WW, Boyd HL (1969) Combined hormone control therapy and radical prostatectomy in the treatment of selected cases of advanced carcinoma of the prostate: a retrospective study based upon 25 years of experience. J Urol 101: 86

    PubMed  CAS  Google Scholar 

  77. Zincke H, Fleming TR, Furlow WL, et al (1981) Radical retropubic prostatectomy and pelvic lymphadenectomy for high-stage cancer of the prostate. Cancer 47: 1901

    Article  PubMed  CAS  Google Scholar 

  78. Walsh PC, Lepor H, Eggleston JC (1983) Radical prostatectomy with preservation of sexual function: anatomical and pathological considerations. Prostate 4: 473

    Article  PubMed  CAS  Google Scholar 

  79. Middleton AW Jr (1981) Pelvic lymphadenectomy with modified radical retropubic prostatectomy as a single operation: technique used and results in 50 consecutive cases.) Urol 125: 353

    Google Scholar 

  80. Linder A, deKernion JB, Smith RB, et al (1983) Risk of urinary incontinence following radical prostatectomy. J Urol 129: 1007

    Google Scholar 

  81. Zincke H, Utz DC, Myers RP, et al (1982) Bilateral pelvic lymphadenectomy and radical retropubic prostatectomy for adenocarcinoma of prostate with regional lymph node involvement. Urology 19: 238

    Article  PubMed  CAS  Google Scholar 

  82. Walsh PC, Donker PJ (1982) Impotence following radical prostatectomy: insight into etiology and prevention. J Urol 128: 492

    PubMed  CAS  Google Scholar 

  83. Neglia WJ, Hussey DH, Johnson DE (1977) Megavoltage radiation therapy for carcinoma of the prostate. Int J Radiat Oncol Biol Phys 2: 873

    Article  PubMed  CAS  Google Scholar 

  84. Leibel SA, Pino Y,Torres JL, et al (1980) Improved quality of life following radical radiation therapy for early stage carcinoma of the prostate. Urol Clin North Am 7: 593

    PubMed  CAS  Google Scholar 

  85. Lupu AN, Petrovic Z, Corvalan J, et al (1982)Teletherapy for stage C adenocarcinoma of the prostate. J Urol 128: 75

    PubMed  CAS  Google Scholar 

  86. Bagshaw MA (1982) Radiation therapy of prostatic carcinoma. In: Crawford ED, Borden TA (eds) Genitourinary cancer surgery. Lea & Febiger, Philadelphia, p 405

    Google Scholar 

  87. Cupps RE, Utz DC, Fleming TR, et al (1980) Definitive radiation therapy for prostatic carcinoma: Mayo Clinic experience. J Urol 124: 855

    PubMed  CAS  Google Scholar 

  88. Pilepich MV, Perez CA, Bauer W (1980) Prognostic parameters in radiotherapeutic management of localized carcinoma of the prostate. J Urol 124: 485

    PubMed  CAS  Google Scholar 

  89. McGowan DG (1980)The adverse influence of priortransurethral resection on prognosis in carcinoma of the prostate treated by radiation therapy. Int J Radiat Oncol Biol Phys 6:1121

    Article  PubMed  CAS  Google Scholar 

  90. Pistenma DA, Bagshaw MA, Freiha FS (1979) Extended-field radiation therapy for prostatic adenocarcinoma: status report of a limited prospective trial. In: Johnson DE, Samuels ML (eds) Cancer of the genitourinary tract. Raven Press, NewYork, p 229

    Google Scholar 

  91. Perez CA, Bauer W, Garza R, et al (1977) Radiation therapy in the definitive treatment of localized carcinoma of the prostate. Cancer 40: 1425

    Article  PubMed  CAS  Google Scholar 

  92. Bagshaw MA (1979) Perspectives on radiation treatment of prostate cancer: history and current focus. In: Murphy GP (ed) Prostatic cancer. P.S.G. Publishing Company, Littleton, p 151

    Google Scholar 

  93. Hanks GE, Leibel S, Kramer S (1983) The dissemination of cancer by transurethral resection of locally advanced prostate cancer.) Urol 129: 309

    CAS  Google Scholar 

  94. Hoffman GS, Scardino PT, Carlton CE Jr (1983) The effect of TU RP on survival and dissemination in prostatic cancer. Proc Meeting American Urological Association, Las Vegas, 195 (abstract # 416)

    Google Scholar 

  95. Lange PH, Moon TD, Haselow RE, et al (1983) Radiation therapy after radical prostatectomy. Proc Meeting American Urological Association, Las Vegas, 166 (abstract # 300)

    Google Scholar 

  96. Smith JA Jr, Harris TH, Middleton RG (1983) Clinical effects of external irradiation on patients with lymph node metastases from prostatic cancer. Proc Meeting American Urological Association, Las Vegas, 167 (abstract # 301)

    Google Scholar 

  97. Perez CA, Ackerman LV, Silber I, et al (1974) Radiation therapy in the treatment of localized carcinoma of the prostate. Preliminary report using 22-MeV photons. Cancer 34: 1059

    Article  PubMed  CAS  Google Scholar 

  98. Hill DR, Crews QE Jr, Walsh PC (1974) Prostate carcinoma: radiation treatment of the primary and regional lymphatics. Cancer 34: 156

    Article  PubMed  CAS  Google Scholar 

  99. Whitmore WF Jr (1980) Interstitial radiation therapy for carcinoma of the prostate. Prostate 1: 157

    Article  PubMed  Google Scholar 

  100. Kandzari SJ, Belis JA, Riley RS (1983) Post-radiation biopsy and histological effects in early stage prostatic cancertreated with 125iodine implants. Proc Meeting American Urological Association, Las Vegas 165 (abstract # 296)

    Google Scholar 

  101. Herr HW(1979) Complication of pelvic lymphadenectomyand retropubic prostatic 1251 implantation. Urology 14:226

    Article  PubMed  CAS  Google Scholar 

  102. Ross G Jr, Borkon WD,Landry LJ,et al(1982) Prel im inaryobservations on the result of combined 125iodine seed implantation and external irradiation for carcinoma of the prostate.) Urol 127:699

    Google Scholar 

  103. Cumes DM, Goffinet DR, Martinez A, et al (1981) Complications of 125iodine implantation and pelvic lymphadenectomyfor prostatic cancerwith special reference to patients who had failed external beam therapy as their initial mode of therapy. J Urol 126: 620

    PubMed  CAS  Google Scholar 

  104. Scardino PT, Cuerriero WG, Carlton CE Jr (1982) Surgical staging and combined therapy with radioactive gold grain implantation and external irradiation. In: Johnson DE, Boileau MA (eds) Genitourinary tumors: fundamental principles and surgical techniques. Crune & Stratton, New York, p 75

    Google Scholar 

  105. Court B, Chassagne D (1977) Interstitial radiation therapy of cancer of the prostate using iridium 192 wires. Cancer Treat Rep 61: 329

    PubMed  CAS  Google Scholar 

  106. Leach GE, Cooperi F, Kagan AR, et al (1982) Radiotherapy for prostatic carcinoma: post-irradiation prostatic biopsy and recurrence patterns with long-term follow-up. J Urol 128: 505

    PubMed  CAS  Google Scholar 

  107. Benson RC Jr, Hasan SM, JonesAG, etal (1982) External beam radiotherapyfor palliation of pain from metastatic carcinoma of the prostate. J Urol 127: 69

    PubMed  Google Scholar 

  108. Rowland CG, Bullimore JA, Smith PJB, et al (1981) Half-body irradiation in the treatment of metastatic prostatic carcinoma. Br J Urol 53: 628

    Article  PubMed  CAS  Google Scholar 

  109. Keen CW (1980) Half body radiotherapy in the management of metastatic carcinoma of the prostate.) Urol 123: 713

    CAS  Google Scholar 

  110. Kraus PA, Lytton B, Weiss RM, et al (1972) Radiation therapy for local palliative treatment of prostatic cancer.) Urol 108: 612

    CAS  Google Scholar 

  111. Walsh PC, Siitieri PK (1975) Suppression of plasma androgens by spironolactone in castrated men with carcinoma of the prostate. J Urol 114: 254

    PubMed  CAS  Google Scholar 

  112. Senge T, Hulshoff T, Tunn V, et al (1982) Testosteron-Konzentration im Serum nach subkapsulärer Orchiektomie. Urologe 17: 382

    Google Scholar 

  113. Altwein JE, Bandhauer K (1976) Langzeituntersuchungen dertestikulär-hypophysären Wechselbeziehung beim Prostatakarzinom. Akt Urol 7: 101

    Google Scholar 

  114. Glashan RW, Robinson MRG (1981) Cardiovascular complications in the treatment of prostatic carcinoma. Br J Urol 53: 624

    Article  PubMed  CAS  Google Scholar 

  115. Geller J, Albert J, Yen SSC (1978) Treatment of advanced cancer of prostate with megestrol acetate. Urology 12: 537

    Article  PubMed  CAS  Google Scholar 

  116. Corbin A (1982) From contraception to cancer: a review of the therapeutic applications of LH RH analogues as antitumor agents. Yale J Biol Med 55: 27

    PubMed  CAS  Google Scholar 

  117. Huggins C, Hodges CV (1941) Studies on prostatic cancer; effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res 1: 293

    CAS  Google Scholar 

  118. Labrie F, Dupont A, Belanger A, et al (1982) New hormonal therapy in prostatic carcinoma: combined treatment with a LH-RH agonist and an antiandrogen. Clin Invest Med 5: 267

    PubMed  CAS  Google Scholar 

  119. Sanford EJ, Drago JR, RohnerTJ Jr, et al (1976) Aminoglutethimide medical adrenalectomy for advanced prostatic carcinoma. J Urol 115: 170

    PubMed  CAS  Google Scholar 

  120. Jakse E (Urologische Arbeitsgruppe der Arbeitsgemeinschaft für Chirurgische Onkologie) (1987) Manual der Urologischen Krebstherapie. Facultas, Wien

    Google Scholar 

Übersichtsarbeiten

  1. Jacobi GH (1982) Tumoren der Prostata und Samenblase. In: Hohenfellner R (Hrsg) Urologie in Klinik und Praxis, Bd 1.Thieme, Stuttgart New York, S 566 (Im Text zitiert unter [641)

    Google Scholar 

  2. Catalona WJ, Scott WW (1986) Carcinoma of the prostate. In: Walsh PC, Giftes RF, Perlmutter AD, et al (eds) Campbell’s urology, vol 2. Saunders, Philadelphia, p 1463 (Im Text zitiert unter [19])

    Google Scholar 

Download references

Authors
  1. C. P. Schmidbauer
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag/Wien

About this paper

Cite this paper

Schmidbauer, C.P. (1990). Prostatakarzinom. In: Prostatakarzinom Malignes Melanom Bildgebende Verfahren in der Onkologie. Angewandte Onkologie. Springer, Vienna. https://doi.org/10.1007/978-3-7091-9107-1_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-9107-1_1

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-82228-9

  • Online ISBN: 978-3-7091-9107-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation